High-Grade B-Cell Lymphoma With Malignant Effusions as the Initial Presentation
American Journal of Clinical Pathology · 2023
DOI: 10.1093/ajcp/aqac182 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2023. Verfasst von Zubaidah Al-Jumaili und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, Houston, TX, US. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Objectives
Malignant effusion is usually caused by metastatic carcinoma. Malignant lymphoma is often not included as a top differential diagnosis of malignant effusion. Here, we describe 3 cases of young female patients with no significant past medical history who presented with fluid overload and were diagnosed with high-grade B-cell lymphoma (HGBL).
Methods
We conducted histopathologic examination and immunophenotypic and cytogenetic analyses on three cases using immunohistochemistry, flow cytometry, fluorescence in situ hybridization (FISH), and karyotyping. We also included patients’ clinical and radiological findings in our case reports.
Results
Histologic examination of the effusion samples showed numerous intermediate to large lymphoma cells with irregular nuclear contours and fine chromatin. The lymphoma cells were positive for CD10, CD20, BCL2, BCL6, and PAX5 and negative for CD34, cyclin D1, HHV-8, and TdT. In situ hybridization for Epstein-Barr virus (EBV)–encoded small RNAs was negative. The proliferation index by Ki-67 stain was more than 80%. Flow cytometry showed CD10-positive B cells with monotypic immunoglobulin light chain expression. Fluorescence in situ hybridization analysis demonstrated MYC, BCL2, or BCL6 rearrangements. These 3 patients were diagnosed as having HGBL with double-/triple-hit rearrangements. Despite receiving aggressive chemotherapy, all 3 patients had a dismal clinical course, with 2 patients dying less than 2 years after initial diagnosis.
Conclusions
High-grade B-cell lymphoma should be considered in the differential diagnoses of malignant effusions. Flow cytometric and FISH analyses of the body fluid specimens are essential to reach an accurate and timely diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, Houston, TX, US.
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
- Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
ORCID-Profile: Zubaidah Al-Jumaili, Ahmed Ahmed
Zitieren
APA
Al-Jumaili, Z., Helen Zhang, Y., Wang, W. J., Mai, B., Wang, X. I., Ahmed, A., Wang, W., Hu, S., James You, M., & Hu, Z. (2023). High-Grade B-Cell Lymphoma With Malignant Effusions as the Initial Presentation. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqac182
Vancouver
Al-Jumaili Z, Helen Zhang Y, Wang WJ, Mai B, Wang XI, Ahmed A, et al. High-Grade B-Cell Lymphoma With Malignant Effusions as the Initial Presentation. American Journal of Clinical Pathology. 2023. doi:10.1093/ajcp/aqac182
BibTeX
@article{AlJumaili2023,
author = {Al-Jumaili, Zubaidah and Helen Zhang, Y and Wang, Wei J and Mai, Brenda and Wang, Xiaohong I and Ahmed, Ahmed and Wang, Wei and Hu, Shimin and James You, M and Hu, Zhihong},
title = {High-Grade B-Cell Lymphoma With Malignant Effusions as the Initial Presentation},
journal = {American Journal of Clinical Pathology},
year = {2023},
doi = {10.1093/ajcp/aqac182}
}
EUVIMED